NYSE to Commence Delisting Proceedings Against Trinseo PLC (TSE)

NEW YORK--(BUSINESS WIRE)-- The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Trinseo PLC (the “Company”) — ticker symbol TSE — from the NYSE. Trading in the Company’s ordinary shares will be suspended immediately.

NYSE Regulation reached its decision to delist the Company’s ordinary shares pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s ordinary shares upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260302947785/en/

Company Contact:
Bee van Kessel
Tel: + 1 835 235 0735
Email: [email protected]

NYSE Contact:
NYSE Communications
[email protected]

Source: NYSE Regulation

You May Also Be Interested In

• Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
• Best Crypto Presale to Buy in 2026? Can Remittix’s 300M RTX Burn Plan Outshine Solana and Zcash?
• Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026